However, this certainly does not apply to the pharmaceutical industry, as Sandra Phlippen discovered. Physical proximity between organisations plays a much smaller role than expected when it comes to gaining access to valuable external knowledge about new medicines.
On Wednesday 5 November 2008, Phlippen will be defending her dissertation Come close and co create. Proximities in pharmaceutical innovation networks, at Erasmus University Rotterdam, the Netherlands.
For her dissertation, Sandra Phlippen examined how different forms of proximity between organisations affect their capacity for strategic collaboration, which in recent years has become increasingly important in the pharmaceutical industry. Previously new medicines were mostly brought out by the laboratories of the large pharmaceutical companies, but their long period of hegemony is well and truly over. The lack of successful internal medicines, the expiry of patent rights from past successes, and finally the enormous expansion of alternative technology for the development of medicines have prompted pharmaceutical companies to explore opportunities for working together with external partners. As a result, innovations in the biopharmaceutical industry generally occur through partnerships between biotech companies, universities and pharmaceutical companies.
Phlippen made a distinction in her research between the effect of co-location (geographical proximity), the effect of being embedded in a network (relational proximity) and the effect of being in a common knowledge field (cognitive proximity). She discovered that the effect of geographical clustering is very limited, in spite of the many billions that are being invested in setting up business parks for companies and universities. “It is much more important for organisations to be ‘embedded’ in (often international) networks based on previous strategic partnerships. New partnership links for developing medicines are primarily the result of both organisations having a common partner with whom they have worked in the past. What matters, therefore, is not where you are, but whom you know,” explains Sandra Phlippen.
Once a collaborative partnership between two organisations has been established, it is important that there is sufficient common, that is, overlapping. knowledge between them. At the same time, the number of external partnerships cannot be too great, because knowledge about new medicines is so complex that the transfer of knowledge between two organisations requires the same researchers to work on both external and internal projects. It is only under this condition that knowledge that has been acquired externally can be successfully applied internally.
Yvette Nelen | alfa
Uncovering decades of questionable investments
18.01.2018 | University of Texas at Austin, Texas Advanced Computing Center
Corporate coworking as a driver of innovation
22.11.2017 | Fraunhofer-Institut für Arbeitswirtschaft und Organisation IAO
On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.
We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...
What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...
For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.
Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...
At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.
No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...
Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.
Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...
08.01.2018 | Event News
11.12.2017 | Event News
08.12.2017 | Event News
22.01.2018 | Materials Sciences
22.01.2018 | Earth Sciences
22.01.2018 | Life Sciences